11 Nov 2025

Advestra Advises Novartis on USD 6.0 Billion Notes Issuance

"Advestra advised Novartis on the placement of notes in the aggregate principal amount of USD 6.0 billion. The issuance comprised seven tranches — six fixed-rate and one floating-rate — issued by Novartis Capital Corporation and guaranteed by Novartis."

Advestra represented client(s) Novartis in connection with the placement of USD 6.0 billion in notes. The transaction involved the issuance of notes in the aggregate principal amount of USD 6.0 billion. The offering was structured into seven tranches, six of which were fixed-rate notes and one a floating-rate note. The notes were issued by Novartis Capital Corporation and guaranteed by Novartis. Advestra represented client(s) Novartis with a team composed by: Annette Weber (capital markets), Thomas Reutter (capital markets), Mariëlle van Nimwegen (capital markets) and Céline Martin (tax).
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.